Cargando…
Viral polymerase inhibitors T-705 and T-1105 are potential inhibitors of Zika virus replication
Since 2015, 69 countries and territories have reported evidence of vector-borne Zika virus (ZIKV) transmission. Currently, there are no effective licensed vaccines or drugs available for the treatment or prevention of ZIKV infection. We tested a series of compounds for their ability to inhibit ZIKV...
Autores principales: | Cai, Lei, Sun, Yajie, Song, Yabin, Xu, Likun, Bei, Zhuchun, Zhang, Dongna, Dou, Yuanyuan, Wang, Hongquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5563514/ https://www.ncbi.nlm.nih.gov/pubmed/28597088 http://dx.doi.org/10.1007/s00705-017-3436-8 |
Ejemplares similares
-
Improving properties of the nucleobase analogs T-705/T-1105 as potential antiviral
por: Jia, Xiao, et al.
Publicado: (2021) -
Design, Synthesis, and Biological Evaluation of Benzimidazole Derivatives as Potential Lassa Virus Inhibitors
por: Chen, Jinwei, et al.
Publicado: (2023) -
Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
por: FURUTA, Yousuke, et al.
Publicado: (2017) -
A Viral Polymerase Inhibitor Reduces Zika Virus Replication in the Reproductive Organs of Male Mice
por: Jacobs, Sofie, et al.
Publicado: (2019) -
Naphthoquine: A Potent Broad-Spectrum Anti-Coronavirus Drug In Vitro
por: Song, Yabin, et al.
Publicado: (2022)